Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings

Bradley S. Johnson; William Roberts; Jonathan Riddle; Cole Wayant; Jared Scott; Matt Vassar

doi:10.1016/j.urology.2019.11.042

Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings

Bradley S. Johnson, William Roberts, Jonathan Riddle, Cole Wayant, Jared Scott, Matt Vassar

Oklahoma State University Center for Health Sciences

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	Urology
Volume	137
DOIs	https://doi.org/10.1016/j.urology.2019.11.042
State	Accepted/In press - 1 Jan 2020

Access to Document

10.1016/j.urology.2019.11.042

Cite this

@article{6dc23b6963124209833d6cb8118e4d8b,

title = "Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings",

author = "Johnson, {Bradley S.} and William Roberts and Jonathan Riddle and Cole Wayant and Jared Scott and Matt Vassar",

year = "2020",

month = jan,

day = "1",

doi = "10.1016/j.urology.2019.11.042",

language = "English",

volume = "137",

pages = "1--6",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier",

}

TY - JOUR

T1 - Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings

AU - Johnson, Bradley S.

AU - Roberts, William

AU - Riddle, Jonathan

AU - Wayant, Cole

AU - Scott, Jared

AU - Vassar, Matt

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85078346857&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2019.11.042

DO - 10.1016/j.urology.2019.11.042

M3 - Article

C2 - 31911084

AN - SCOPUS:85078346857

SN - 0090-4295

VL - 137

SP - 1

EP - 6

JO - Urology

JF - Urology

ER -

Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings

Access to Document

Other files and links

Cite this